In another nationwide cohort study assessing the risk of depression in diabetic patients receiving GLP-1 agonists, Tsai et al 16 demonstrated evidence of a lower combined incidence of anxiety and/or depression in GLP-1 RA users than in nonusers
Brain Res 99:354358
All animals were single-housed two weeks prior to treatment and throughout the remainder of the study period
Curie A, Touil N, Gaillard S, Galanaud D, Leboucq N, Deschenes G, Morin D, Abad F, Luaute J, Bodenan E, Roche L, Acquaviva C, Vianey-Saban C, Cochat P, Cotton F, Bertholet-Thomas A (2020) Neuropsychological and neuroanatomical phenotype in 17 patients with cystinosis
Prior to initiating VYVANSE treatment, screen patients for risk factors for developing a manic episode (e.g., comorbid or history of depressive symptoms or a family history of suicide, bipolar disorder, and depression)
We believe everyone deserves to celebrate their most glowing self, and were here to make that celebration easy and delightful